Medical and Regulatory Advisors

Medical Advisor Board

Physicians, Psychiatrists & Healthcare Practitioners – being built

Remi A Menes BSc, MBA, Chairman of the CanaQuest, Advisory Committees
  • Extensive commercial, operations and business development experience in the biopharmaceutical, biotech, pharmaceutical, and cannabinoid sector.
  • Experience with launching pharmaceutical products; developing product life-cycle management strategies; establishing head office, division and field capabilities – in Canada, USA, Japan, Latin America and Western Europe.

Advisor Expertise and Shared Values:

  • Scientific knowledge and expertise in cannabinoid-based medicine
  • Currently or amenable to prescribing cannabinoids
  • MD Advisors recommended by Strategic Investment Partner (TBD).



Regulatory Advisors

Dr. Tom Ng B.S., Ph.D., COO, BioPharma Global, Regulatory Consultants

– 7 Leadership Team Members

  • Ng’s academic background includes a B.S. in Biochemistry from the University of Maryland and a Ph.D. in Molecular Biology from Johns Hopkins University. He is also an Executive Board Member and President Emeritus of the CMNS Alumni Association Chapter at the University of Maryland;
  • BioPharma Global is a full-service regulatory affairs consulting firm specializing in orphan products to treat rare diseases and non-orphan products;
  • The team is comprised of globally recognized experts in rare diseases and other under-served disease areas, including former FDA staff.
Eurofins Scientific

Eurofins Scientific

Eurofins Scientific through its subsidiaries is the world leader in food, environment, pharmaceutical and cosmetic products testing and in agroscience CRO services. It is also one of the global independent market leaders in testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and for supporting clinical studies. In addition, Eurofins is one of the key emerging players in specialty esoteric and molecular clinical diagnostic testing in Europe and the USA. With 58,000 staff across a network of more than 1,000 independent companies in 54 countries and operating 900 laboratories, Eurofins offers a portfolio of over 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostics.